Volume 25, Number 2—February 2019
Research Letter
West Nile Virus Infection in Travelers Returning to United Kingdom from South Africa
Table
Test | Result | Reference range | Day of testing† |
---|---|---|---|
Blood tests | |||
White cell count | 12.2 × 109 cells/L | 3.5–9.5 × 109/L | 1 |
C-reactive protein | 81 mg/L | 0–5 mg/L | 1 |
Creatine kinase | 593 U/L | 25–200 U/L | 1 |
Glucose |
7 mmol/L |
3–6 mmol/L |
1 |
Liver function tests | |||
Alkaline phosphatase | 60 IU/L | 30–130 IU/L | 3 |
Aspartate aminotransferase | 33 IU/L | 0–32 IU/L | 3 |
Gamma glutamyl transferase | 78 IU/L | 0–40 IU/L | 3 |
Gamma glutamyl transferase | 155 IU/L | 0–40 IU/L | 11 |
Alanine aminotransferase | 35 IU/L | 0–33 IU/L | 3 |
Alanine aminotransferase |
37 IU/L |
0–33 IU/L |
6 |
Malaria testing | |||
Rapid antigen detection‡ | Negative | 1 | |
Thick/thin blood films |
Negative |
1, 2, 3 |
|
Lumbar puncture | |||
Visual appearances | Clear, colorless CSF | 2 | |
Opening pressure | 22 cm H2O | 5–18 cm H2O | 2 |
Leukocyte count | 102 × 106 cells/L | <5 × 106 cells/L | 2 |
Leukocyte differential | 80% polymorphonuclear cells; 20% lymphocytes | ||
CSF protein | 1.24 g/L | 0.15–0.45 g/L | 2 |
CSF glucose |
3 mmol/L |
3.3–4.4 mmol/L |
2 |
CSF molecular assays | |||
Herpes simplex virus DNA | Not detected | 2 | |
Varicella zoster virus DNA | Not detected | 2 | |
Enterovirus RNA | Not detected | 2 | |
Meningococcus DNA | Not detected | 2 | |
Pneumococcus DNA | Not detected | 2 | |
Listeria DNA |
Not detected |
2 |
|
Serology and blood cultures | |||
Blood cultures | No growth after 5 d | 1, 3, 5 | |
HIV screen | Negative | 3 | |
Syphilis screen |
Negative |
3 |
|
Imaging and EEG | |||
Chest radiograph | Unremarkable | 1 | |
Contrast MRI of the brain | No leptomeningeal enhancement; established right cerebellar infarct | 5 | |
EEG | Rhythmic irregular delta slow-wave activity (suggestive of encephalopathy) | 11 |
*CSF, cerebrospinal fluid; EEG, electroencephalogram; MRI, magnetic resonance imaging.
†After hospital admission.
‡Plasmodium lactate dehydrogenase (pLDH) test (OptiMAL-IT, Bio-Rad, http://www.bio-rad.com).
Page created: January 18, 2019
Page updated: January 18, 2019
Page reviewed: January 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.